Elevance Health, Inc. (ELV), 2024 Q4 earnings digest

$ELV has released its Q4 2024 earnings, reporting adjusted diluted earnings per share of $3.84 amidst elevated Medicaid cost trends and solid growth in Medicare Advantage with 7-9% expected for 2025. Key stats show revenue of $175.2 billion, while membership decreased by 1.1 million due to Medicaid adjustments. As for profitability, 2025 guidance estimates adjusted EPS in the range of $34.15 to $34.85. Future risks include elevated costs in Medicaid and the impact of regulatory changes.